NeuroLambda Therapeutics

Cambridge, United States

NeuroLambda Therapeutics is a company.

$3.0M raised

Jul 2024

Seed

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NeuroLambda Therapeutics

How much funding has NeuroLambda Therapeutics raised?

NeuroLambda Therapeutics has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in July 2024.

Where is NeuroLambda Therapeutics headquartered?

NeuroLambda Therapeutics is headquartered in Cambridge, United States.

What does NeuroLambda Therapeutics do?

NeuroLambda Therapeutics is a company.

What stage is NeuroLambda Therapeutics at?

NeuroLambda Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 17, 2024.

MLA

"NeuroLambda Therapeutics — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/neurolambda-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2024). NeuroLambda Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/neurolambda-therapeutics

Wikipedia (cite web)

{{cite web |title=NeuroLambda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neurolambda-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 17, 2024.